We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in the Cards for Mettler-Toledo's (MTD) Q1 Earnings?
Read MoreHide Full Article
Mettler-Toledo International, Inc. (MTD - Free Report) is scheduled to report first-quarter 2021 results on May 6.
For the first quarter, the company expects sales growth between 11% and 13% on a year-over-year basis in local currency. The Zacks Consensus Estimate for the same is pegged at $758.3 million, indicating growth of 16.8% from the year-ago reported figure.
Further, adjusted quarterly earnings are anticipated to be $5.55-$5.70 per share, implying a 39%-43% rise from the year-ago quarter’s reported figure. The consensus mark for the same is projected at $5.65 per share, reflecting a rise of 41.2% from the year-ago quarter.
We note the company surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average beat being 11.8%.
MettlerToledo International, Inc. Price and EPS Surprise
The impacts of Mettler-Toledo’s solid momentum across Laboratory, Food Retailand Industrial segments are expected to get reflected in the soon-to-be-reported quarterly results.
Further, portfolio strength, cost-cutting efforts, robust sales and marketing strategies, and margin and productivity initiatives are expected to have aided first-quarter performance.
Additionally, the company’s robust automated chemistry solutions are expected to have aided Mettler-Toledo’s momentum across the drug process development field in the first quarter.
Furthermore, its investments in product portfolio expansion, field force, Spinnaker sales and marketing programs are likely to have driven sales growth for the Laboratory Instruments segment in the quarter under review.
Also, strong momentum across pharmaceutical and life sciences markets is expected to have benefited the segment in the quarter under discussion.
Apart from this, solid momentum across the core industrial business is likely to have driven the Industrial Instruments segment’s sales in the to-be-reported quarter.
Additionally, strengthening momentum across the Food Retail segment is expected to have contributed well to the company’s top-line growth in the first quarter.
However, softness in the product inspection business of the company is anticipated to get reflected in the first-quarter results of the company.
Further, headwinds related to the coronavirus outbreak are likely to have posed challenges for the company in the to-be-reported quarter.
What Our Model Says
Our proven model does not conclusively predict an earnings beat for Mettler-Toledo this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Mettler-Toledo has an Earnings ESP of -1.42% and a Zacks Rank #3.
Stocks to Consider
Here are some companies, which have the right combination of elements to post an earnings beat this quarter:
Synaptics Incorporated (SYNA - Free Report) currently has an Earnings ESP of +1.60% and carries a Zacks Rank of 2.
CDW Corporation (CDW - Free Report) has an Earnings ESP of +0.51% and a Zacks Rank of 2 at present.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.
Image: Bigstock
What's in the Cards for Mettler-Toledo's (MTD) Q1 Earnings?
Mettler-Toledo International, Inc. (MTD - Free Report) is scheduled to report first-quarter 2021 results on May 6.
For the first quarter, the company expects sales growth between 11% and 13% on a year-over-year basis in local currency. The Zacks Consensus Estimate for the same is pegged at $758.3 million, indicating growth of 16.8% from the year-ago reported figure.
Further, adjusted quarterly earnings are anticipated to be $5.55-$5.70 per share, implying a 39%-43% rise from the year-ago quarter’s reported figure. The consensus mark for the same is projected at $5.65 per share, reflecting a rise of 41.2% from the year-ago quarter.
We note the company surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average beat being 11.8%.
MettlerToledo International, Inc. Price and EPS Surprise
MettlerToledo International, Inc. price-eps-surprise | MettlerToledo International, Inc. Quote
Key Factors to Consider
The impacts of Mettler-Toledo’s solid momentum across Laboratory, Food Retailand Industrial segments are expected to get reflected in the soon-to-be-reported quarterly results.
Further, portfolio strength, cost-cutting efforts, robust sales and marketing strategies, and margin and productivity initiatives are expected to have aided first-quarter performance.
Additionally, the company’s robust automated chemistry solutions are expected to have aided Mettler-Toledo’s momentum across the drug process development field in the first quarter.
Furthermore, its investments in product portfolio expansion, field force, Spinnaker sales and marketing programs are likely to have driven sales growth for the Laboratory Instruments segment in the quarter under review.
Also, strong momentum across pharmaceutical and life sciences markets is expected to have benefited the segment in the quarter under discussion.
Apart from this, solid momentum across the core industrial business is likely to have driven the Industrial Instruments segment’s sales in the to-be-reported quarter.
Additionally, strengthening momentum across the Food Retail segment is expected to have contributed well to the company’s top-line growth in the first quarter.
However, softness in the product inspection business of the company is anticipated to get reflected in the first-quarter results of the company.
Further, headwinds related to the coronavirus outbreak are likely to have posed challenges for the company in the to-be-reported quarter.
What Our Model Says
Our proven model does not conclusively predict an earnings beat for Mettler-Toledo this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Mettler-Toledo has an Earnings ESP of -1.42% and a Zacks Rank #3.
Stocks to Consider
Here are some companies, which have the right combination of elements to post an earnings beat this quarter:
Agilent Technologies, Inc. (A - Free Report) presently has an Earnings ESP of +1.57% and a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Synaptics Incorporated (SYNA - Free Report) currently has an Earnings ESP of +1.60% and carries a Zacks Rank of 2.
CDW Corporation (CDW - Free Report) has an Earnings ESP of +0.51% and a Zacks Rank of 2 at present.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022.
Click here for the 4 trades >>